Valid Ghana · FDA Ghana

PICOVAX

INACTIVATED POLIOVIRUS TYPE 1(BRUNHILDE), INACTIVATED POLIOVIRUS TYPE 2 (MEF-1), INACTIVATED POLIOVIRUS TYPE 3 (SAUKETT)

FDA/HVC/251-04006 INACTIVATED POLIOVIRUS TYPE 1(BRUNHILDE), INACTIVATED POLIOVIRUS TYPE 2 (MEF-1), INACTIVATED POLIOVIRUS TYPE 3 (SAUKETT) EACH 0.5ML DOSE IS FORMULATED TO CONTAIN INACTIVATED POLIOVIRUS TYPE 1(BRUNHILDE) ≥ 3.2 D-ANTIGEN UNITS, INACTIVATED POLIOVIRUS TYPE 2 (MEF-1) ≥ 0.88 D-ANTIGEN UNITS, INACTIVATED POLIOVIRUS TYPE 3 (SAUKETT)≥ 3.1 D-ANTIGEN UNITS SUSPENSION FOR INJECTION INN generic

What it does

Inactivated vaccines help your body build protection against certain diseases without causing the disease itself.

Commonly used for: prevention of infectious diseases

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/HVC/251-04006
Registration date
2025-04-28
Expiry date
2028-04-01
Status
Valid
Active ingredient
INACTIVATED POLIOVIRUS TYPE 1(BRUNHILDE), INACTIVATED POLIOVIRUS TYPE 2 (MEF-1), INACTIVATED POLIOVIRUS TYPE 3 (SAUKETT)
Strength
EACH 0.5ML DOSE IS FORMULATED TO CONTAIN INACTIVATED POLIOVIRUS TYPE 1(BRUNHILDE) ≥ 3.2 D-ANTIGEN UNITS, INACTIVATED POLIOVIRUS TYPE 2 (MEF-1) ≥ 0.88 D-ANTIGEN UNITS, INACTIVATED POLIOVIRUS TYPE 3 (SAUKETT)≥ 3.1 D-ANTIGEN UNITS SUSPENSION FOR INJECTION
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Aj Vaccines
Country of origin
DENMARK
Manufacturer location
Artillerivej 5, 2300 København, Denmark

Source: Food and Drugs Authority · fetched 2026-04-18 08:37:38 · updated 2026-10-20 04:00:14

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About inactivated

Inactivated vaccines help your body build protection against certain diseases without causing the disease itself.

What it treats

  • prevention of infectious diseases

How it works

Inactivated vaccines contain viruses or bacteria that have been killed or inactivated, so they cannot cause disease. They stimulate your immune system to recognize and fight off the real infection if you are exposed in the future.

Who it's for

These vaccines are generally given to people of all ages, based on specific health recommendations.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About poliovirus

Poliovirus is a virus that can cause poliomyelitis, a serious illness affecting the nervous system.

What it treats

  • prevention of poliomyelitis (polio)

How it works

The vaccine helps the body develop immunity to the poliovirus, preventing the disease.

Who it's for

It is given to children and adults to protect against polio.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: inactivated

Inactivated vaccines are a type of immunization that use pathogens that have been killed or inactivated through physical or chemical processes. Unlike live vaccines, inactivated vaccines do not replicate in the host but still stimulate an immune response. These vaccines are generally considered safe and are commonly used to prevent various infectious diseases.

Indications

  • Hepatitis A
  • Hepatitis B
  • Influenza
  • Polio
  • Rabies
  • Typhoid fever

Dosage

Children: Refer to specific product guidelines for paediatric dosing, as it varies by vaccine type and indication.

Adults: Refer to specific product guidelines for adult dosing, as it varies by vaccine type and indication.

Mechanism of action

Inactivated vaccines work by introducing a form of the pathogen that cannot cause disease into the body. This stimulates the immune system to produce antibodies and memory cells specific to the pathogen, allowing for a robust immune response upon future exposure. The immune system recognizes the inactivated pathogen as foreign, leading to the activation of T-cells and B-cells, which are crucial for long-term immunity.

Pharmacodynamics

The pharmacodynamics of inactivated vaccines involve the generation of an adaptive immune response. After vaccination, the body produces specific antibodies against the inactivated pathogen. The response typically includes both humoral immunity, characterized by antibody production, and cellular immunity, involving T-cell activation. The duration of immunity can vary, and booster doses may be required to maintain adequate protection.

Pharmacokinetics

Inactivated vaccines do not have a pharmacokinetic profile like traditional drugs since they do not enter systemic circulation in the same manner. Following administration, the vaccine components are taken up by antigen-presenting cells, which process and present the antigens to T-cells. The immune response is initiated locally at the site of injection and can be influenced by factors such as the route of administration and the presence of adjuvants that enhance the immune response.

Adverse effects

  • Injection site reactions (pain, swelling, redness)
  • Fever
  • Fatigue
  • Headache
  • Myalgia
  • Chills

Precautions

  • Assess for allergies to vaccine components
  • Monitor for allergic reactions post-administration
  • Consider underlying health conditions that may affect immune response

Pregnancy

Inactivated vaccines are generally considered safe during pregnancy, but individual risk-benefit assessment is recommended.

Breast-feeding

Inactivated vaccines can be administered during breastfeeding without concern for adverse effects in the infant.

Storage

Store in a refrigerator at 2°C to 8°C. Do not freeze.

Formulations

  • Inactivated viral vaccines
  • Inactivated bacterial vaccines

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: poliovirus

Poliovirus is an enterovirus of the Picornaviridae family, known for causing poliomyelitis, a potentially debilitating viral infection. The virus primarily spreads through the fecal-oral route and can lead to paralysis in a small percentage of infected individuals. Vaccination has led to a significant decline in cases worldwide, with the inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV) being the main preventive measures.

Indications

  • Poliomyelitis prevention
  • Vaccination against poliovirus
  • Public health immunization programs

Dosage

Children: Refer to national immunization guidelines for childhood vaccination schedules, including IPV and OPV.

Adults: Refer to national immunization guidelines, typically involving a series of vaccinations with IPV or OPV.

Mechanism of action

Poliovirus infects host cells by binding to specific receptors on the cell surface, leading to the internalization of the virus. Once inside, poliovirus releases its RNA genome, which hijacks the host's cellular machinery to replicate and produce viral proteins. This replication can cause cell lysis and inflammation, leading to symptoms of the disease.

Pharmacodynamics

Poliovirus primarily targets motor neurons in the spinal cord and brainstem, resulting in cell death and, subsequently, muscle weakness or paralysis. The severity of the disease varies significantly, with many infections being asymptomatic, while a minority progress to paralytic disease. The immune response to the infection plays a crucial role in determining the outcome.

Pharmacokinetics

The pharmacokinetics of poliovirus is characterized by its ability to survive in the gastrointestinal tract, where it replicates before entering the bloodstream. The virus does not undergo conventional pharmacokinetic processes such as absorption, distribution, metabolism, or excretion like typical drugs, as it is a living organism. The duration of viral shedding can vary, typically lasting from a few weeks to several months, depending on the individual’s immune response.

Adverse effects

  • Mild fever
  • Fatigue
  • Headache
  • Sore throat
  • Nausea
  • Vomiting
  • Diarrhea
  • Flu-like symptoms
  • Rarely, paralytic poliomyelitis

Precautions

  • Monitor for signs of allergic reactions
  • Patients with immunocompromised states should be assessed carefully
  • Individuals should be screened for history of vaccine-associated paralytic poliomyelitis

Pregnancy

The inactivated poliovirus vaccine (IPV) is considered safe during pregnancy. Live attenuated vaccines are generally avoided.

Breast-feeding

IPV is safe for breastfeeding mothers. Live attenuated vaccines may have specific recommendations.

Storage

Store at 2 to 8 degrees Celsius. Do not freeze.

Formulations

  • Inactivated poliovirus vaccine (IPV)
  • Oral poliovirus vaccine (OPV)

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.